EMS SA - Company Profile

Powered by

All the sales intelligence you need on EMS SA in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how EMS SA fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with EMS SA.

Back to companies

EMS SA: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of the health and well-being of the population. The company operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC, and hospitals. Its major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, topical corticosteroids, anti-ulcers, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and Hortolandia in Sao Paulo; Novamed, Manaus in Amazonas; and Brasilia in Federal District. The company is certified by European Medicines Agency. EMS is headquartered in Hortolandia, Brazil.

 Gain a 360-degree view of EMS SA and make more informed decisions for your business Gain a 360-degree view of EMS SA and make more informed decisions for your business Learn more
Headquarters Brazil
Address Rod Journalist Francisco Aguirre Proenca, 08 KM, Neighborhood Chacara Assay, Hortolandia, Sao Paulo, 13186-901
Website www.ems.com.br
Industry Pharmaceuticals and Healthcare
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

EMS SA premium industry data and analytics

480+

Marketed Drugs

Understand EMS SA’s commercialized product portfolio to stay one step ahead of the market.

80+

Clinical Trials

Determine EMS SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for EMS SA’s relevant decision makers and contact details.

60+

Catalyst Calendar

Proactively evaluate EMS SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

5

Pipeline Drugs

Identify which of EMS SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for EMS SA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on EMS SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Prescription Drugs Sigmasporin
Over The Counter Drugs Energil C
Branded Drugs Gelmax
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand EMS SA portfolio and identify potential areas for collaboration Understand EMS SA portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Contracts/Agreements In April, the company entered into an agreement with miRecule, for the development of RNA technology for rare diseases.
2026 Contracts/Agreements In March, the company entered into an agreement with Sanofi, for the purchase and sale of 100% of Medley, one of Brazil's leading generic drug brands.
2025 Asset Purchase In November, the company announced the acquisition of the assets in Anapolis (GO) from the German multinational Fresenius Kabi.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters EMS SA Eurofarma Laboratorios SA Ache Laboratorios Farmaceuticos SA Laboratorio Teuto Brasileiro SA Biotecnica Industria E Comercio Ltda
Headquarters Brazil Brazil Brazil Brazil Brazil
City Hortolandia Sao Paulo Guarulhos Anapolis Varginha
State/Province Sao Paulo Sao Paulo Sao Paulo Goias Minas Gerais
No. of Employees - 13,000 6,000 - -
Entity Type Private Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Marcus Sanchez Vice President Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into EMS SA key executives to enhance your sales strategy Gain insight into EMS SA key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?